4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001827672-22-000002
Options or other derivatives
- President and CEO acquired 199,264 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Azamian Bobak R. · President and CEO
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-03-09 | Grant or award : show line 1 in the form Stock Option (right to buy) | +154,067 | $19.59 | 2032-03-08 | 154,067 | 154,067 | D |
| 2022-03-09 | Grant or award : show line 2 in the form Restricted Stock Units | +45,197 | 45,197 | 45,197 | D |
Loading xslF345X03/wf-form4_164703352044513.xml…